Neoplasms Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Data Collection, Clinical Care and Interventions in CCR, NCI
Enrolling by invitation
  • Neoplasms
  • Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-10-14
    Oct 14, 2021
    N
    Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
    Recruiting
    • Neoplasms
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2021-10-14
      Oct 14, 2021
      B
      This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer.
      Active, not recruiting
      • Neoplasms
      • Breast Neoplasms
      • Santa Monica, California
      • +29 more
      2021-10-13
      Oct 13, 2021
      J
      Peer Support Program in Cancer Patients Elkar Laguntza
      Recruiting
      • Neoplasms
      • +2 more
      • Peer support program
      • San Sebastián, Guipuzcoa, Spain
        Onkologikoa
      2021-09-30
      Sep 30, 2021
      B
      A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread - 2020
      Terminated
      • Neoplasms
      • +2 more
      • BI 891065
      • BI 754091
      • Sarasota, Florida
      • +2 more
      2021-10-07
      Oct 7, 2021
      E
      A Study of E7386 in Combination With Other Anticancer Drug in Participants With Solid Tumor
      Recruiting
      • Neoplasms
      • +2 more
      • Kashiwa, Chiba, Japan
      • +2 more
      2021-10-06
      Oct 6, 2021
      N
      Collection of Tissue Samples for Cancer Research
      Recruiting
      • Neoplasms
      • +3 more
        • Iowa City, Iowa
        • +6 more
        2021-10-13
        Oct 13, 2021
        B
        A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors)
        Recruiting
        • Neoplasms
        • San Antonio, Texas
        • +3 more
        2021-10-12
        Oct 12, 2021
        N
        5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
        Recruiting
        • Neoplasms
        • Solid Tumors
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2021-10-12
        Oct 12, 2021
        H
        Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
        Recruiting
        • RET-altered Non Small Cell Lung Cancer
        • +39 more
        • pralsetinib (BLU-667)
        • Phoenix, Arizona
        • +78 more
        2021-10-09
        Oct 9, 2021
        I
        Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)
        Recruiting
        • Digestive System Disease
        • Neoplasms
        • EPODIG-G program (coordination of supportive care)
        • Strasbourg, France
          Institut de cancérologie Strasbourg Europe
        2021-10-04
        Oct 4, 2021
        B
        Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma - 2020
        Completed
        Has Results
        • Neoplasms
        • Bellinzona, Switzerland
        • +5 more
        2021-09-14
        Sep 14, 2021
        N
        Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
        Suspended
        • Neoplasms
        • Solid Tumors
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2021-10-08
        Oct 8, 2021
        J
        A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors
        Recruiting
        • Neoplasms
        • Los Angeles, California
        • +10 more
        2021-10-07
        Oct 7, 2021
        J
        A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
        Recruiting
        • Neoplasms
        • Saint Louis, Missouri
        • +32 more
        2021-10-07
        Oct 7, 2021
        J
        A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS
        Active, not recruiting
        • Neoplasms
        • +3 more
        • Sarasota, Florida
        • +17 more
        2021-10-07
        Oct 7, 2021
        J
        A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors
        Not yet recruiting
        • Neoplasms
        • Haifa, Israel
        • +4 more
        2021-10-07
        Oct 7, 2021
        B
        A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
        Active, not recruiting
        • Neoplasms
        • BI 754091
        • Sarasota, Florida
        • +12 more
        2021-10-05
        Oct 5, 2021
        B
        This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours)
        Recruiting
        • Neoplasms
        • BI 905677
        • Los Angeles, California
        • +4 more
        2021-10-05
        Oct 5, 2021
        G
        My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
        Active, not recruiting
        • Neoplasms
        • +4 more
        • Goodyear, Arizona
        • +60 more
        2021-10-06
        Oct 6, 2021
        G
        Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Pediatric Participants With Solid Tumors
        Recruiting
        • Neoplasms
        • Lille, France
        • +10 more
        2021-09-30
        Sep 30, 2021
        P
        BRAF V600E-mutant Colorectal Cancer Study of Encorafenib Taken With Cetuximab Plus or Minus Chemotherapy (BREAKWATER)
        Recruiting
        • Neoplasms
        • Duarte, California
        • +76 more
        2021-10-06
        Oct 6, 2021
        M
        A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)
        Recruiting
        • Neoplasms
        • +3 more
        • V941
        • Pembrolizumab
        • Gilbert, Arizona
        • +25 more
        2021-10-06
        Oct 6, 2021
        F
        Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation
        Recruiting
        • Liver Metastases
        • +3 more
        • Ancona, Italy
        • +11 more
        2021-10-06
        Oct 6, 2021
        B
        BI 894999 First in Human Dose Finding Study in Advanced Malignancies
        Active, not recruiting
        • Neoplasms
        • NUT Carcinoma
        • BI 894999
        • Boston, Massachusetts
        • +15 more
        2021-10-05
        Oct 5, 2021